EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 27 filers reported holding EVOKE PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $77,000 | -49.0% | 30,062 | -7.2% | 0.00% | -100.0% |
| Q3 2020 | $151,000 | +32.5% | 32,387 | 0.0% | 0.00% | – |
| Q2 2020 | $114,000 | +208.1% | 32,387 | 0.0% | 0.00% | – |
| Q1 2020 | $37,000 | -28.8% | 32,387 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | +92.6% | 32,387 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | +35.0% | 32,387 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -58.3% | 32,387 | 0.0% | 0.00% | – |
| Q1 2019 | $48,000 | -40.0% | 32,387 | 0.0% | 0.00% | – |
| Q4 2018 | $80,000 | -16.7% | 32,387 | 0.0% | 0.00% | – |
| Q3 2018 | $96,000 | -6.8% | 32,387 | -21.7% | 0.00% | -100.0% |
| Q2 2018 | $103,000 | +53.7% | 41,387 | +27.8% | 0.00% | – |
| Q1 2018 | $67,000 | -8.2% | 32,387 | 0.0% | 0.00% | – |
| Q4 2017 | $73,000 | – | 32,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 32,000 | $83,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 65,004 | $168,000 | 0.03% |
| Virtu Financial LLC | 18,335 | $47,000 | 0.01% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,540 | $9,000 | 0.01% |
| Cetera Advisor Networks LLC | 30,260 | $78,000 | 0.00% |
| Creative Planning | 100,000 | $258,000 | 0.00% |
| Renaissance Technologies | 187,276 | $483,000 | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 36,768 | $95,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |